GROWTH FORECAST FOR AFRICAN PHARMA MARKET

7 December 1992

The market for pharmaceutical products in Africa (excluding South Africa) is forecast to reach $2.7 billion by 1996, rising 35% from the current $2 billion level, according to the latest edition of IMS affiliate Research Consult-ants International's African Barometer 1992. Based on its annual survey of 30 countries, RCI measures the value of both imports (at cif prices) and local output (at ex-factory prices).

Egypt maintained its position as the leading market in dollar value terms, followed by Algeria and Morocco. However, in 1991, Tunisia overtook Nigeria to take fourth place, with a strong 24% increase in market value, against Nigeria's 2% dec-line in sales.

In terms of per capita consumption of medicines, Gabon emerged as the leading market, closely followed by Libya, as shown in the table below. *t Per Capita Pharmaceutical Market - 1991 $ ------------------------------------------------------------------------ Gabon $25.1 million Libya $24.2 million Tunisia $18.7 million Mauritius $16.7 million Algeria $10.5 million Cote d'Ivoire $9.7 million Botswana $9.5 million Egypt $7.8 million Senegal $7.4 million ------------------------------------------------------------------------ $t

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight